Please login to the form below
chronic lung disease
This page shows the latest chronic lung disease news and features for those working in and with pharma, biotech and healthcare.
Detailed results for Regeneron's antibody cocktail continue to show benefit in high-risk COVID-19 outpatients
All participants in this trial had at least one risk factor for developing severe COVID-19, including chronic lung disease, obesity, cardiovascular disease or were at least 50 years of age. ... In the US, REGEN-COV is authorised for emergency use to
Latest news
-
AZ, Sanofi’s nirsevimab hits primary endpoint in RSV trial
palivizumab) among preterm infants and children with chronic lung disease (CLD) and congenital heart disease (CHD).
-
Roche’s flu pill Xofluza gains EU approval
This includes influenza patients who have conditions including asthma, chronic lung disease, diabetes, heart disease or morbid obesity or adults aged 65 and over.
-
Moderna’s COVID-19 vaccine could offer protection for ‘a couple of years’, says CEO
On Wednesday, the European Commission granted Moderna’s COVID-19 vaccine, initially called mRNA-1273, a conditional marketing authorisation to prevent the disease in people aged 18 years and older. ... The trial also showed a 90.9% efficacy rate in
-
Moderna wins EU authorisation for COVID-19 vaccine
The trial also showed a 90.9% efficacy rate in participants who were at risk of developing severe COVID-19 infection, including people with chronic lung disease, heart disease, obesity, liver ... disease, diabetes or HIV infection.
-
EMA recommends authorisation of Moderna’s COVID-19 vaccine
The trial also showed a 90.9% efficacy rate in participants who were at risk of developing severe COVID-19 infection, including people with chronic lung disease, heart disease, obesity, liver ... disease, diabetes or HIV infection.
AZ, Sanofi’s nirsevimab hits primary endpoint in RSV trial
Roche’s flu pill Xofluza gains EU approval
Moderna’s COVID-19 vaccine could offer protection for ‘a couple of years’, says CEO
Moderna wins EU authorisation for COVID-19 vaccine
EMA recommends authorisation of Moderna’s COVID-19 vaccine
More from news
Approximately 1 fully matching, plus 22 partially matching documents found.
Latest from PMHub
-
October 2020: diversity and inclusion in clinical trials round-up
People with chronic conditions such as diabetes, lung disease, and heart disease, and those of advanced age, had a poorer prognosis once infected with COVID-19. ... In the U.S., fewer healthcare providers have training, knowledge, and expertise in
October 2020: diversity and inclusion in clinical trials round-up
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Senior Consultant, Pricing & Market Access Consultancy, circ...
-
circa £100K package
- Principal/ Senior/ Medical Writer – Global Med Ed and Comms Agen...
-
Highly competitive salary
-
Digital account director
-
Competitive
- Project Director, Healthcare Marketing Agency patient focus Lond...
-
Highly competitive salary
- Digital Project Director, Healthcare Marketing Agency patient fo...
-
Highly competitive salary
-
Events Executive
-
Depending on Experience
- Account Manager - Healthcare Consultancy
-
Salary depending on experience
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Mixing AZ and Pfizer COVID-19 vaccines increases antibody levels
- CHMP rejects Kyowa Kirin’s Parkinson’s disease drug
- Novavax announces further delays for regulatory filings of COVID-19 vaccine
- Google’s DeepMind opens ‘breakthrough’ protein database to the world
- Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’
- Lilly and Kumquat Biosciences link up in $2bn-plus immuno-oncology deal
- Michael J. Fox Foundation and IBM reveal new AI model for Parkinson’s disease
- BMS’ Q2 results beat expectations with strong performance across core therapy areas
- Amanda Pritchard becomes NHS England’s first female chief executive
- Understanding the ‘real world’ starts and ends with the patient
No results were found
PMHub
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...
Latest intelligence
- Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
- The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
- Employee wellbeing in creative agencies: three tips to get you started
- Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
- Managing unhelpful pressure in your creative agency: the human approach
- Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...
